A Comparison of People's Responses to the Labels "Natural Immunity" Versus "Disease-induced Immunity".
NCT07102485 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350
Last updated 2025-08-03
Summary
A comparison of how people respond to the terms "natural immunity" versus "disease-induced immunity".
Conditions
- Attitudes
Interventions
- OTHER
-
disease-induced immunity
Using a different label for natural immunity, specifically, "disease-induced immunity"
- OTHER
-
natural immunity
Using standard label "natural immunity"
Sponsors & Collaborators
-
Laval University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-24
- Primary Completion
- 2025-08-31
- Completion
- 2025-08-31
More Related Trials
-
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management
NCT04668170 ·Status: COMPLETED
-
Understanding COVID-19
NCT04329546 ·Status: COMPLETED
-
Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients
NCT04892797 ·Status: TERMINATED
-
Characterisation of the Immune Response to SARS-CoV-2 / COVID-19
NCT04729452 ·Status: COMPLETED
-
Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19
NCT06142279 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immune Changes in Severe COVID-19 Pulmonary Infections
NCT04386395 ·Status: COMPLETED
-
Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy
NCT02912520 ·Status: COMPLETED
-
Evaluating the Immune Response for COVID-19
NCT04348422 ·Status: COMPLETED
-
Integrated Clinical Prediction Rules: Bringing Evidence to Diverse Primary Care Settings
NCT02534987 ·Status: COMPLETED ·Phase: NA
-
Immunological Characteristics of COVID-19 Patients
NCT04679428 ·Status: UNKNOWN
-
The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study
NCT05258643 ·Status: UNKNOWN ·Phase: NA
-
Immune Status of Elderly Population Admitted in an Acute Geriatric Unit
NCT00823589 ·Status: COMPLETED ·Phase: NA
-
Study on Immune Status of Patients With COVID-19
NCT05682573 ·Status: UNKNOWN
-
(VIII): The Eight Study and Immunologic Response Sub-study
NCT05237024 ·Status: UNKNOWN
-
Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19)
NCT04425759 ·Status: UNKNOWN
-
Microbiome Analysis of Skin and Airway Samples and Effect of Face Masks
NCT04894422 ·Status: UNKNOWN
-
A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis
NCT00042588 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Inflammatory Cytokines During COVID-19
NCT04824495 ·Status: UNKNOWN
-
Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms
NCT04356586 ·Status: COMPLETED
-
Immune Cells Phenotypes During COVID-19
NCT04816760 ·Status: UNKNOWN
-
COVID Cohort Study
NCT04393155 ·Status: TERMINATED
-
Follow-up Study of Population Vaccinated With COVID-19 Vaccine
NCT04972591 ·Status: UNKNOWN
-
COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff
NCT04346186 ·Status: COMPLETED
-
Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)
NCT04498325 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections
NCT02848534 ·Status: COMPLETED